Lyra Therapeutics (LYRA) Earnings
|
Expand Research on LYRA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -782.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/13/25 | Q325 | -$3.38 | $0.00 | -$3.38 | N/A | N/A | N/A |  | | Details | |
8/12/25  |
Q225 | N/A | -$0.17 | N/A | N/A | $242K | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$5.51 | -$0.17 | -$5.34 | $183K | $242K | N/A | | | Details | |
| 5/6/25 |
Q125 | -$0.13 | -$0.12 | -$0.01 | N/A | $102.35K | N/A | | | Details | |
| 3/11/25 |
Q424 | N/A | -$0.19 | N/A | N/A | $324.4K | N/A | N/A | N/A | ||
| 3/10/25 |
Q424 | N/A | -$0.19 | N/A | N/A | $324.4K | N/A | N/A | N/A | ||
| 3/7/25 |
Q424 | N/A | -$0.19 | N/A | N/A | $324.4K | N/A | N/A | N/A | ||
| 3/6/25 |
Q424 | N/A | -$0.19 | N/A | N/A | $324.4K | N/A | N/A | N/A |
